Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating HX009 plus IN10018 with or without standard chemotherapy for advanced solid tumors, including biliary tr…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases [Phase 2]
Phase 2 clinical trial evaluating the combination of binimetinib and encorafenib for metastatic melanoma with CNS metastases is currently re…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]
Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
This clinical trial update describes a study evaluating well-being and health-related quality of life in melanoma patients during the COVID-…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma [Phase 1]
Phase I, open-label study evaluating autologous tumor-infiltrating lymphocytes engineered with membrane-bound IL-15 in adults with metastati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel) [Phase 1]
Phase 1 dose-escalation and expansion study evaluating PRAME TCR-engineered NK cells for recurrent or refractory melanoma; currently recruit…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) [Phase 1]
Phase Ib study investigating alpelisib in combination with pembrolizumab in metastatic breast cancer or melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma [Phase 2]
Phase 2 clinical trial evaluating stereotactic ablative radiotherapy combined with immunotherapy for oligometastatic extracranial melanoma; …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors [Phase 1]
Phase 1 trial comparing HLX18 to nivolumab (Opdivo) in patients with multiple resected solid tumors, including esophageal/gastric cardia can…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps [Phase 1]
A Phase 1 study evaluating different doses of BI 3810944 in adults with advanced cancer, including melanoma, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating IACS-6274 with or without Bevacizumab and Paclitaxel in adults with advanced solid tumors; the study is cu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: ctDNA for Risk Stratification in Melanoma
This clinical trial update describes evaluating circulating tumor DNA (ctDNA) for risk stratification in melanoma.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for Enzelkitug as a single agent and in combination with a checkpoint inhibitor in adults with locally advance…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: NO Re-excision MelanomA - NORMA 2 [Phase 3]
NORMA 2 is a Phase 3 clinical trial in melanoma evaluating a no-reexcision strategy; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
A recruiting clinical trial is evaluating an AI algorithm based on melanoma peri-scar dermatoheliosis as a predictive factor for response to…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Harvesting Cells for Experimental Cancer Treatments
An NCI-sponsored clinical trial update indicates enrollment by invitation for a cell-harvesting approach in experimental cancer therapies ac…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial [NA]
A ClinicalTrials.gov update for the Thrive Track trial aimed at managing emotional support for young adults with thyroid cancer, melanoma, a…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Duration of Anti-PD-1 Therapy in Metastatic Melanoma [Phase 3]
Phase 3 trial update examining the optimal duration of anti-PD-1 therapy for unresectable/metastatic melanoma.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating DOC1021 dendritic cell immunotherapy for refractory melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study [Phase 2]
A Phase 2 immunoMATCH pilot trial (BiCaZO) is evaluating cabozantinib in combination with nivolumab for advanced melanoma and head and neck …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
Clinical trial update for the SHERLOCK platform, a high-precision evaluation of minimal residual disease for cancer tracking and interceptio…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating GB1211 in combination with pembrolizumab versus pembrolizumab with placebo in patients with metastati…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: UK ENcorafenib and BInimetinib Real-world Study in Melanoma
A real-world UK study of encorafenib and binimetinib in metastatic melanoma with a BRAF V600 mutation; the study status is ACTIVE_NOT_RECRUI…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread [Phase 2]
Phase 2 clinical trial update evaluating two different schedules of dabrafenib and trametinib for stage III/IV or unresectable melanoma.